ThermoFisherScientific - Custom and Bulks
Pharma Focus Europe
Worldwide Clinical Trials - Neuroscience Clinical Development

Techno Trends

Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.

Gwangju Institute Reveals Potential Breakthrough Drug for Fatty Liver Disease

Researchers at the Gwangju Institute of Science and Technology Discover a Novel Drug Candidate to Combat Fatty Liver Disease. Metabolic dysfunction-associated steatotic liver disease is a significant global health concern...

First-of-its-Kind FDA Approval for Orchard Therapeutics Lenmeldy™ for Early-onset Metachromatic Leukodystrophy in U.S.

Orchard Therapeutics, now part of Kyowa Kirin, has achieved a significant breakthrough with the approval of Lenmeldy™ by the U.S. Food and Drug Administration. Lenmeldy, previously...

Groundbreaking Protein Dynamics Prediction Technique Revolutionizes Drug Discovery

A group of researchers at Brown University has devised an innovative approach to swiftly predict diverse protein configurations using machine learning. Their method aims...

Moffitt Cancer Center achieves a milestone as FDA approves groundbreaking Tumor-Infiltrating Lymphocyte Therapy for advanced melanoma

The recent approval by the Food and Drug Administration of a novel cellular immunotherapy at Moffitt Cancer Center marks a pivotal moment for patients battling advanced melanoma. This groundbreaking therapy...

Sibeprenlimab Achieves Breakthrough Status from U.S. FDA for Immunoglobulin A Nephropathy Therapy

Otsuka Pharmaceutical Development & Commercialization, Inc, in collaboration with Otsuka Pharmaceutical Co., Ltd, and Visterra, Inc., an Otsuka group company, jointly announce a significant development: the U.S. Food and Drug Administration...

Nuvalent’s First-of-Its-Kind NVL-520 Receives Breakthrough Therapy Designation from U.S. FDA

Nuvalent, a biopharmaceutical company in the clinical stage, has declared that the U.S. Food and Drug Administration has accorded breakthrough therapy designation to NVL-520 for treating individuals...

Iovance Biotherapeutic’s Novel Lifileucel (AMTAGVI™) Receives FDA Approval for Advanced Melanoma Treatment

Iovance Biotherapeutics, a leading biotechnology company committed to pioneering, developing, and delivering innovative polyclonal tumor infiltrating lymphocyte cell therapies for cancer patients...

Latozinemab Secures FDA Breakthrough for FTD-GRN in Progranulin Gene Mutation

Alector recently announced a significant milestone in the potential treatment of Frontotemporal Dementia with a progranulin gene mutation. The U.S. Food and Drug Administration...

Ensysce Biosciences Secures FDA Breakthrough for PF614-MPAR in a Novel Advancement

Ensysce Biosciences, a clinical-stage company dedicated to enhancing prescription drug safety through innovative chemistry, has received notification from the U.S. Food and Drug Administration...

Santhera's AGAMREE® (Vamorolone) Granted First-of-Its-Kind Approval for Duchenne Muscular Dystrophy in the UK

Santhera Pharmaceuticals has recently announced the approval of AGAMREE® in the United Kingdom for the treatment of Duchenne muscular dystrophy in patients aged 4 and above, irrespective of their underlying mutation...

magazine-slider-img
Thermo Fisher Scientific viral vector services (VVS)ThermoFisher - Mastering API production at every scaleFuture Labs Live - 2024World Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva